Categories AlphaGraphs, Earnings, Retail

Conagra Brands (CAG) Q4 profit rises and beats estimates; revenue up 6%

Packaged Foods company Conagra Brands Inc. (NYSE: CAG) on Thursday said its fourth-quarter profit increased supported by a 6% revenue growth. Earnings came in above the consensus forecast while sales missed.

Conagra Brands Q4 2022 earnings infographic

At $2.91 billion, fourth-quarter net sales were up 6% year-over-year. But the top line performance fell short of expectations. Organic sales benefited from an improvement in price/mix, aided by the company’s inflation-driven pricing actions that were reflected in the marketplace throughout the quarter and favorable brand mix.

Fourth-quarter net income, adjusted for special items, moved up to $0.65 per share from $0.54 per share in the same period of last year and topped expectations. Reported profit, meanwhile, declined to $158.9 million or $0.33 per share in the most recent quarter from $309.5 million or $0.64 per share in the fourth quarter of 2022.


Check this space to read management/analysts’ comments on Conagra Brands’ Q4 2022 earnings


“Throughout fiscal 2022 our team took decisive actions to offset inflation and invest in our business. I’m pleased that our brands continued to resonate with consumers, and we continued to grow share,” said Sean Connolly, chief executive officer of Conagra Brands.

Prior Performance

  • Conagra Brands reports Q3 2022 earnings results
  • Conagra Brands Q2 2021
  • Conagra Brands (CAG) Q1 2021 Earnings Infograph

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top